Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Vicore Pharma Holding

10.20 SEK

-0.39 %

Less than 1K followers

VICO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vicore Pharma Holding

2019202020212022202320242025
Revenue109.43.8
growth-%-96.5 %
EBITDA-92.7-146.0-291.2-287.1-255.5-184.0-452.4
EBIT-94.0-149.5-294.8-290.7-321.5-194.2-452.4
Profit before taxes-93.3-147.3-296.7-288.8-311.3-168.9-477.5
Net income-93.1-146.9-296.5-288.4-310.9-168.6-477.5
EPS-2.10-2.37-4.02-3.88-3.13-1.23-1.99
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-168.3 %-11,851.9 %
EBIT-%-177.6 %-11,851.9 %
ROE-28.9 %-41.4 %-77.3 %-99.8 %-68.3 %-14.9 %-43.6 %
ROI-27.3 %-36.1 %-65.7 %-85.2 %-62.7 %-14.0 %-39.1 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.